Method for Producing Rare Fatty Acid Using Novel Enzyme, and Novel Rare Fatty Acid
Nitto Pharmaceutical Industries, Ltd.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,046,980 | Method for Producing Rare Fatty Acid Using Novel Enzyme, and Novel Rare Fatty Acid In force · High confidence UsedRemaining | Noster Inc. | In force | High confidence | ||
| Application 15/113,604 | Method for Producing Rare Fatty Acid Using Novel Enzyme, and Novel Rare Fatty Acid Abandoned Abandoned Oct 9, 2019 | Kyoto University and Nitto Pharmaceutical Industries, Ltd. | Abandoned | Abandoned Oct 9, 2019 |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Nitto Pharmaceutical Industries, Ltd..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.